Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity

Journal of Endocrinological Investigation

Volumn 26, Issue 6, 2003, Pages 588-594

  Janssen, J A M J L ^a   Van Der Lely, A J ^a   Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bp proteases; Free IGF I; IGF I bioactivity; IGFBPs; IRMA; Measurement of free IGF I; Total IGF I; Ultrafiltration

Indexed keywords

ACID LABILE SUBUNIT; CORTICOSTEROID; CREATININE; GROWTH HORMONE; HORMONE RECEPTOR; INSULIN; INSULIN RECEPTOR; PROTEIN; PROTEINASE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THYROID HORMONE; UNCLASSIFIED DRUG;

CALIBRATION; CHRONIC KIDNEY FAILURE; DRUG ACTIVITY; DRUG INFUSION; ENDOCRINE SYSTEM; ENZYME ACTIVITY; EXTRACTION; GENDER; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; IMMUNORADIOMETRIC ASSAY; IN VITRO STUDY; INSULINOMA; METHODOLOGY; OBESITY; REVIEW; SAMPLING; ULTRAFILTRATION;

EID: 0042024921     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345225     Document Type: Review

References (37)

1. McRory J.E., Sherwood N.M. Ancient divergence of insulin and insulin-like growth factor. DNA Cell Biol. 1997, 16: 939-949.
2. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16: 143-163.
3. Dupont J., LeRoith D. Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction. Horm. Res. 2001, 55 (Suppl. 2): 222-26.
4. Sjogren K., Liu J.L., Blad K., et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 1999, 96: 7088-7092.
5. Froesch E.R., Zapf J. Insulin-like growth factors and insulin: Comparative aspects. Diabetologia 1985, 28: 485-493.
6. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 1995, 16: 3-34.
7. Rechler M.M. Non-receptor binding proteins for insulin-like growth factors and other cytokine modulators of peptide action. In: Weintraub B.D. (Ed.), Molecular Endocrinology, Basic Concepts and Clinical Correlations. Raven Press, New York, 1995, pp. 155-180.
8. Cohen P., Rosenfeld R.G. Growth regulation. In: Griffin J.E., Ojeda S.R. (Eds.), Textbook of Endocrine Physiology, 3rd Edition. Oxford University Press, Oxford, 1996, pp 244-259.
9. Collett-Solberg P.F., Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol. Metab. Clin. North Am. 1996, 25: 591-614.
10. Berg U., Gustafsson T., Carlsson-Skwirut C., et al. Local IGF-I in excercising human skeletal muscle determined by microdialysis. Growth Hormone and IGF Research, 2002, 4: 256 (Abstract O97).
11. Bondy C.A., Underwood L.E., Clemmons D.R., Guler H.P., Bach M.A., Skarulis M. Clinical uses of insulin-like growth factor I. Ann. Intern. Med. 1994, 120: 593-601.
12. Yakar S., Liu J.L., Fernandez A.M., et al. Liver-specific IGF-I gene deletion leads to muscle insulin insensitivity. Diabetes 2001, 50: 1110-1118.
13. Cotterill A.M., Holly J.M., Taylor A.M., et al. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. J. Clin. Endocrinol. Metab. 1992, 74: 56-63.
14. Brismar K., Fernqvist-Forbes E., Wahren J., Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 1994, 79: 872-878.
15. Bar R.S., Boes M., Clemmons D.R., et al. Insulin differentially alters transcapillary movement of intravascular IGF-BP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990, 127: 479-497.
16. Nygren J., Carlsson-Skwirut C., Brismar K., Thorell A., Ljungqvist O., Bang P. Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery. Am. J. Physiol. Endocrinol. Metab. 2001, 281: E736-741.
17. Bereket A., Lang C.H., Blethen S.L., Fan J., Frost R.A., Wilson T.A. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. J. Clin. Endocrinol. Metab. 1995, 80: 2282-2288.
18. Anonymus. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 1998, 83: 379-381.
19. Quarmby V., Quan C., Ling V., Compton P., Canova-Davis E. How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy. J. Clin. Endocrinol. Metab. 1998, 83: 1211-1216.
20. Chestnut R.E., Quarmby V. Evaluation of total IGF-I assay methods using samples from Type I and Type II diabetic patients. J. Immunol. Methods 2002; 259: 11-24.
21. Khosravi J., Diamandis A., Mistry J., Durham S., Habei L., Cohn S. Proteolysis of insulin-like growth factor (IGF): An unrecognized analytical and clinical variable. 83th Annual Meeting of the Endocrine Society, Denver, USA, 2001 (Abstract P2-654).
22. Frystyk J., Skjaerbaek C., Dinesen B., Orskov H. Free insulin-like growth factor (IGF-I and IGF-II) in human serum. FEBS Lett. 1994, 348: 185-191.
23. Mendelson C.R. Mechanisms of hormone action. In: Griffin J.E., Ojeda S.R. (Eds.) Textbook of Endocrine Physiology, 3th Edition Oxford University Press, Oxford, 1996, p. 30.
24. Tollefsen S.E., Thompson K., Petersen D.J. Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography. J. Biol. Chem. 1987, 262: 16461-16469.
25. Chapman I.M., Hartman M.L., Pieper K.S., et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I. J. Clin. Endocrinol. Metab. 1998, 83: 2836-2842.
26. Frystyk J., Vestbo E., Skjaerbaek C., Mogensen C.E., Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995, 44 (Suppl. 4): 37-44.
27. Moller N., Frystyk J., Skjaerbaek C., et al. Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: Role of increased levels of free insulin-like growth factors. Diabetologia 1996, 39: 1534-1535.
28. Frystyk J., Skjaerbaek C., Zapf J., Orskov H. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 1998, 41: 589-594.
29. Simpson H.L., Caroll P.V., Gayle C., Frystyk J., Orskov H., Sonksen P.H. Free insulin-like growth factor-I and non-islet cell tumour hypoglycemia. 84th Annual Meeting of the Endocrine Society, San Francisco, USA, 2001 (Abstract P3-547).
30. Frystyk J., Ivarsen P., Skjaerbaek C., Flyvbjerg A., Pedersen E.B., Orskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999,56: 2076-2084.
31. Bang P., Ahlsen M., Berg U., Carlsson-Skwirut C. Free insulin-like growth factor I: Are we hunting a ghost? Horm. Res. 2001, 55 (Suppl. 2): 84-93.
32. Lieberman S.A., Bukar J., Chen S.A., et al. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J. Clin. Endocrinol. Metab. 1992, 75: 30-36.
33. Hizuka N., Takano K., Asakawa K., et al. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul. 1991, 1: 51-55.
34. Frystyk J., Ivarsen P., Stoving R.K., et al. Determination of free insulin-like growth factor-I in human serum: Comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm. IGF Res. 2001, 11: 117-127.
35. Lee P.D., Powell D., Baker B., et al. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I. 76th Annual Meeting of the Endocrine Society, Anaheim, USA, 1994, (Abstract 939).
36. Juul A., Holm K., Kastrup K.W., et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J. Clin. Endocrinol. Metab. 1997, 82: 2497-2502.
37. Chestnut R., Lee-Tung K., Quarmby V. What do free IGF-I assays actually measure? Method validation using mathematical modeling. 79th Annual Meeting of the Endocrine Society, Minneapolis, USA, 1997. (Abstract p. 3-122).